Security key
05464T104
Axsome Therapeutics, Inc. - Common Stock (AXSM)
CUSIP: 05464T104
Q1 2018 13F Holders as of 31 Mar 2018
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 4,234,235
- Total 13F value
- $10,372,895
- Share change
- -1,590,507
- SEC-reported price per share
- $2.45
- Number of holders
- 35
- Value change
- -$6,125,369
- Number of buys
- 17
- Number of sells
- 17
- Shares outstanding
- 48,932,355
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2018
Institutions
35
Top holders
10
AXSM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2018
Previous quarter: Q4 2017
Axsome Therapeutics, Inc. SEC filings
Axsome Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05464T104
Recent filing periods:
Ownership snapshot
Top reported holders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JPMORGAN CHASE & CO
Disclosed value leader
JPMORGAN CHASE & CO
Comparable rows
15/15
Latest evidence
31 Dec 2017
13F
Lead comparable stake: 3%
Showing 1-6 of 15 holder rows.
Quick read
JPMORGAN CHASE & CO leads the comparable SEC ownership view at 3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JPMORGAN CHASE & CO's linked filing trail.
Comparable ownership
Top 5
JPMORGAN CHASE & CO
3%
FMR LLC
2.5%
ROYCE & ASSOCIATES LP
1.8%
VANGUARD GROUP INC
1%
STIFEL FINANCIAL CORP
0.85%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13F
Company
|
3%
|
$8,153,000
1,455,864 shares
|
— | 31 Dec 2017 |
| FMR LLC |
13F
Company
|
2.5%
|
$6,753,000
1,205,812 shares
|
— | 31 Dec 2017 |
| ROYCE & ASSOCIATES LP |
13F
Company
|
1.8%
|
$4,934,000
881,000 shares
|
— | 31 Dec 2017 |
| VANGUARD GROUP INC |
13F
Company
|
1%
|
$2,743,000
489,752 shares
|
— | 31 Dec 2017 |
| STIFEL FINANCIAL CORP |
13F
Company
|
0.85%
|
$2,326,000
415,279 shares
|
— | 31 Dec 2017 |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
Company
|
0.62%
|
$1,686,000
301,000 shares
|
— | 31 Dec 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
35
Shares
4,234,235
Rows available
35
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
33
Q1 2018 holders
35
Holder diff
2
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 value | Q1 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend